Vai al contenuto principale della pagina

Coronaviruses Research in BRICS Countries



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Autore: Fielding Burtram C Visualizza persona
Titolo: Coronaviruses Research in BRICS Countries Visualizza cluster
Pubblicazione: Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica: 1 online resource (168 p.)
Soggetto topico: Epidemiology and Medical statistics
Medicine and Nursing
Soggetto non controllato: aerosol
bioinformatics and vaccine development
Brazil
breakthrough
convalescent plasma
coronavirus disease 2019 (COVID-19)
corticosteroids
COVID-19
COVID-19 and nanotechnology
COVID-19 testing
Delta and Delta plus variant
dental aerosol-generating procedures
detection
diabetes
different settings
E484K
epitope coverage
extra-oral suction
genomic epidemiology
high-volume evacuation
hospital mortality
humoral response
immunoassay
India
intervention strategies
intubation
low-volume saliva ejector
models
nanomedicine in South Africa
nanotechnology
neutralizing antibody (NAb)
NSW
protein microarray
quantitative antibody binding
reverse zoonosis
SARS-CoV-2
SARS-CoV-2 antibodies
SARS-CoV-2 nucleocapsid protein
severe acute respiratory syndrome coronavirus (SARS-CoV-2)
splatter
treatment
vaccine
vaccine development in South Africa
variant of Interest
VRDL
wildlife
Persona (resp. second.): SchäferGeorgia
FieldingBurtram C
Sommario/riassunto: SARS-CoV-2 has infected more than 105 million people worldwide. During this pandemic, researchers and clinicians have been working to understand the molecular mechanisms that underpin viral pathogenesis by studying viral-host interactions. Now, with the global rollout of various COVID-19 vaccines-based on the neutralization of the spike protein using different technologies-viral immunology and cell-based immunity are being investigated. Researchers are also studying how various SARS-CoV-2 genetic mutations will impact the efficacy of these COVID-19 vaccines. At the same time, various antiviral drugs have been identified or repurposed that have potential as anti-SARS-CoV-2 treatments. BRICS (Brazil, Russia, India, China, and South Africa) is the acronym used to associate five major emerging national economies. The BRICS countries are known for their significant influence on regional affairs, including being leaders in scientific and clinical research and innovation. This Special Issue includes researchers from BRICS countries, in particular South Africa, involved in the study of SARS-CoV-2 and COVID-19. Original articles, as well as new perspectives or reviews on the matter, were welcomed. Research in the fields of vaccine studies, pathogenesis, genetic mutations, viral immunology, and antiviral drugs were especially encouraged.
Titolo autorizzato: Coronaviruses Research in BRICS Countries  Visualizza cluster
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910576885303321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui